164 related articles for article (PubMed ID: 23879903)
1. Phase II study of everolimus in metastatic urothelial cancer.
Smith AB; Pruthi RS
BJU Int; 2013 Aug; 112(4):427-8. PubMed ID: 23879903
[No Abstract] [Full Text] [Related]
2. Phase II study of everolimus in metastatic urothelial cancer.
Milowsky MI; Iyer G; Regazzi AM; Al-Ahmadie H; Gerst SR; Ostrovnaya I; Gellert LL; Kaplan R; Garcia-Grossman IR; Pendse D; Balar AV; Flaherty AM; Trout A; Solit DB; Bajorin DF
BJU Int; 2013 Aug; 112(4):462-70. PubMed ID: 23551593
[TBL] [Abstract][Full Text] [Related]
3. Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.
Gerullis H; Ecke TH; Janusch B; Arndt C; Heidari M; Oniani J; Otto T
Anticancer Drugs; 2011 Oct; 22(9):940-3. PubMed ID: 21642839
[TBL] [Abstract][Full Text] [Related]
4. Management of disseminated disease in the patient with bladder cancer.
Perry JJ; Muss HB
Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.
Seront E; Rottey S; Sautois B; Kerger J; D'Hondt LA; Verschaeve V; Canon JL; Dopchie C; Vandenbulcke JM; Whenham N; Goeminne JC; Clausse M; Verhoeven D; Glorieux P; Branders S; Dupont P; Schoonjans J; Feron O; Machiels JP
Ann Oncol; 2012 Oct; 23(10):2663-2670. PubMed ID: 22473592
[TBL] [Abstract][Full Text] [Related]
6. Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.
Ortmann CA; Mazhar D
Future Oncol; 2013 Nov; 9(11):1637-51. PubMed ID: 24156324
[TBL] [Abstract][Full Text] [Related]
7. Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
Sonpavde G; Bellmunt J; Rosenberg JE; Regazzi AM; Bajorin DF; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Fougeray R; Wong YN; Sridhar SS; Ko YJ; Milowsky MI; Galsky MD; Pond GR
Clin Genitourin Cancer; 2014 Dec; 12(6):395-8. PubMed ID: 25035282
[No Abstract] [Full Text] [Related]
8. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
[TBL] [Abstract][Full Text] [Related]
9. [Systemic chemotherapy of urothelial cancer].
Wolff JM; Jakse G
Urologe A; 1992 May; 31(3):W19-24. PubMed ID: 1615589
[No Abstract] [Full Text] [Related]
10. Chemotherapy for advanced urothelial cancer.
Yagoda A
Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
[No Abstract] [Full Text] [Related]
11. A phase II trial of temsirolimus in second-line metastatic urothelial cancer.
Gerullis H; Eimer C; Ecke TH; Georgas E; Freitas C; Kastenholz S; Arndt C; Heusch C; Otto T
Med Oncol; 2012 Dec; 29(4):2870-6. PubMed ID: 22447503
[TBL] [Abstract][Full Text] [Related]
12. Targeted agents in second-line bladder cancer therapy.
Gerullis H; Otto T; Ecke TH
Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698
[TBL] [Abstract][Full Text] [Related]
13. Urothelial cancers: using biology to improve outcomes.
Pezaro C; Liew MS; Davis ID
Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of urothelial tumors of the bladder].
Culine S; Guastalla JP; Théodore C; Droz JP
Bull Cancer Radiother; 1994; 81(4):303-11. PubMed ID: 7702915
[No Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy of bladder cancer.
Freiha FS; Torti FM
Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
[No Abstract] [Full Text] [Related]
16. Determining superior first-line therapy in metastatic bladder cancer.
Apolo AB
Nat Rev Urol; 2019 Dec; 16(12):698-699. PubMed ID: 31558843
[No Abstract] [Full Text] [Related]
17. Current and new strategies in immunotherapy for superficial bladder cancer.
Perabo FG; Müller SC
Urology; 2004 Sep; 64(3):409-21. PubMed ID: 15351555
[No Abstract] [Full Text] [Related]
18. [New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma].
Le Brun IC; Benderra MA
Bull Cancer; 2021 Sep; 108(9):784-786. PubMed ID: 34332742
[No Abstract] [Full Text] [Related]
19. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Bouffioux C
Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
[No Abstract] [Full Text] [Related]
20. Systemic chemotherapy for urothelial cancer.
Sonpavde G; Hutson TE; Berry WR
Clin Genitourin Cancer; 2006 Jun; 5(1):34-42. PubMed ID: 16859577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
